SCHEMBL5206139

SCHEMBL5206139

CC1=NN(c2cccc(C(=O)O)c2)C(=O)C1N=NC1C(=O)N(c2ccc(C)c(C)c2)N=C1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.51
▸ KMT2A Q03164 9/20 0.51
▸ NPC1 O15118 3/20 0.51
▸ MAPT P10636 9/20 0.50
▸ ALDH1A1 P00352 6/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ L3MBTL1 Q9Y468 4/20 0.47
▸ GAA P10253 4/20 0.47
▸ HPGD P15428 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ HTT P42858 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ MYC P01106 1/20 0.45
▸ HSPA1A P0DMV8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206134 1.00 MEN1 (0.51) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5206131 1.00 MEN1 (0.51) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5202292 0.90 MEN1 (0.53) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5202290 0.90 MEN1 (0.53) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5202286 0.90 MEN1 (0.53) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5206330 0.90 MAPT (0.50) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5206340 0.90 MAPT (0.50) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5202737 0.90 MAPT (0.50) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5202448 0.86 MEN1 (0.51) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL5202444 0.86 MEN1 (0.51) MEN1KMT2ANPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1223944-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2007-01-03 — — EP claimed
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US claimed
JP-2003509462-A — — 2003-03-11 — — JP claimed
EP-1223944-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-10-30 — — EP claimed
EP-1223944-A1 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2002-07-24 — — EP claimed
WO-2001021180-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-03-29 — — WO claimed
EP-1223944-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2007-01-03 — — EP disclosed
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US disclosed
EP-1223944-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-10-30 — — EP disclosed
EP-1223944-A1 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2002-07-24 — — EP disclosed
WO-2001021180-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-03-29 — — WO disclosed
Send feedback